Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
|
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [41] Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTS):: S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9
    Court, MH
    Duan, SX
    Guillemette, C
    Journault, K
    Krishnaswamy, S
    Von Moltke, LL
    Greenblatt, DJ
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) : 1257 - 1265
  • [42] Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone
    Thibaudeau, J
    Lépine, J
    Tojcic, J
    Duguay, Y
    Pelletier, G
    Plante, M
    Brisson, J
    Têtu, B
    Jacob, S
    Perusse, L
    Bélanger, A
    Guillemette, C
    CANCER RESEARCH, 2006, 66 (01) : 125 - 133
  • [43] Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers
    Dong Guo
    Liang-Fang Pang
    Yang Han
    Hong Yang
    Guo Wang
    Zhi-rong Tan
    Wei Zhang
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2013, 69 : 843 - 849
  • [44] Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity
    Takekuma, Yoh
    Takenaka, Toru
    Yamazaki, Koujiro
    Ueno, Kazuyuki
    Sugawara, Mitsuru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) : 2146 - 2153
  • [45] The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers
    Levesque, E.
    Delage, R.
    Benoit-Biancamano, M-O
    Caron, P.
    Bernard, O.
    Couture, F.
    Guillemette, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 392 - 400
  • [46] Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
    Sutliff, Aimee K.
    Shi, Jian
    Watson, Christy J. W.
    Hunt, Martina S.
    Chen, Gang
    Zhu, Hao-Jie
    Lazarus, Philip
    MOLECULAR PHARMACOLOGY, 2019, 96 (06) : 674 - 682
  • [47] In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes
    Dong, Dong
    Zhang, Tianpeng
    Lu, Danyi
    Liu, Jie
    Wu, Baojian
    XENOBIOTICA, 2017, 47 (04) : 277 - 283
  • [48] Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers
    Guo, Dong
    Pang, Liang-Fang
    Han, Yang
    Yang, Hong
    Wang, Guo
    Tan, Zhi-rong
    Zhang, Wei
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 843 - 849
  • [49] Preparation of a Specific Monoclonal Antibody against Human UDP-Glucuronosyltransferase (UGT) 1A9 and Evaluation of UGT1A9 Protein Levels in Human Tissues
    Oda, Shingo
    Nakajima, Miki
    Hatakeyama, Masahiko
    Fukami, Tatsuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1620 - 1627
  • [50] Identification of Human UGT2B7 as the Major Isoform Involved in the O-Glucuronidation of Chloramphenicol
    Chen, Mei
    LeDuc, Barbara
    Kerr, Stephen
    Howe, David
    Williams, David A.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 368 - 375